chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On an unknown date in 2016, a healthcare provider administered the ZOSTAVAX to the patient. On or about 17-AUG-2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of her injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not  limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Red itchy spot at injection site.  About 2 inches by 2 inches square. First came 7 days after the shot. By day 9 it was going away.
Probable shingles in upper right chest, upper right back, and back of right arm (vaccination in left arm); This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 14Apr2021 at 14:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levonorgestrel (MIRENA), vitamin d nos (VITAMIN D) and multivitamin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021, the patient experienced probably shingles in upper right chest, upper right back, and back of right arm (vaccination in left arm). The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with valtrex. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event probably shingles in upper right chest, upper right back, and back of right arm was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
I received my second Moderna booster for COVID-19 on 4/8/2022. Sometime in July 2022, I woke up one morning with a sore throat. Usually, if I wake up with a sore throat, it goes away quickly. However, this didn't go away, so I decided to take a home test for COVID-19. When I did, I got a positive result. For the most part, my symptoms were mild. I had a sore throat, a little bit of nasal congestion, some sinus drainage in the throat, and a little bit of congestion in the upper respiratory area. I also had fatigue, which I would say was worst symptom. The sore throat and the sinus drainage and congestion lasted for about 3 days. The fatigue lasted for 2 weeks, however. I informed my doctor of the situation, and she suggested that if I needed to, I could just take Mucinex and any OTC nasal decongestant to treat the symptoms. Fortunately, though, I never had to take any medicine. I've actually had colds that were worse than this. Even though it's been several months, some of the fatigue still lingers. The other symptoms resolved, however.
Case number PHEH2015US026934 is a spontaneous report initially received from a nurse on 22 Dec 2015. This report refers to a 64 years old male patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with FLURIVIN (batch number: 1514501 and expiry date: May 2016) into the left deltoid on 08 Oct 2015. It was reported that FLUVIRIN administered to the patient had a temperature excursion of 34 degrees. The reporter stated that she did not know why the refrigerator was out of temperature range for an unspecified amount of time overnight. She checked the temperature before she left for the day and when she arrived the next day and the temperature was fine. It was a new refrigerator and there have not been any problems since the temperature excursion. No adverse reaction was experienced by the patient following the maladministration. No further information provided. Follow up information received from the nurse on 26 Jan 2016: Reporter's comment updated.
Patient and her son arrived at the pharmacy stating that patient's lips were swollen. I observed patient and gave 20 ml of diphenhydramine 12.5mg/5 ml. Patient stated that she felt fine and continued to work. I recommended that patient see a physician but patient refused.
I already had itching in my ear for about three months.  Had been tested for an infection, diagnosed at one time with eczema.  After the shot, the infection came out of my ears completely and was down my neck and on the outside of my ears.  I have rosacea, which I have never had before.  It is gradually resolving or seems to becoming less red.  I had a rash on my lower back for a week that has gone away.  I have tiny red bumps on my nose today.  After the rash came out of my ears, I left the ENT and went to a dermatologist.  She noticed the rosacea.  I thought it was just warm in the room.  She said it was definitely rosacea.  I am going to take allergy tests on the 22nd through the 26, going back three times before I get results.  I truly have no idea if the vaccine caused this or not but several people told me I should report it.  The itching cleared up for two weeks and is not back but inside my ears and I had that before I took the booster so it's not related.  Just sending this because I want to  help inform.
hot flashes; This is a spontaneous report based on the information received by Pfizer from a contactable consumer.  A female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech Covid-19 vaccine) via an unspecified route of administration at a single dose on 29Dec2020 for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 29Dec2020, it was reported that the patient received the COVID vaccine "yesterday" and was having hot flashes that went away after 2 hours. Event onset date was unknown. The event resolved on an unspecified date.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a dental hygienist concerning a her "11 year old" son who on approximately 20-MAY-2009 was vaccinated with a second dose of VARIVAX (Merck) (Lot # not reported). In the same day he received Tdap in different arm. After got the vaccines he experienced an injection site reaction to both vaccines. The injection sites were swollen (3 inches diameter ball), red and hot to the touch. The patient was told to take BENADRYL and on 26-MAY-2007 the patient had stomach ache. The patient sought unspecified medical attention. The hygienist also mentioned that her son friend's went to the same office and got Tdap and MENACTRA and also had an unspecified reaction to both. There were no laboratories diagnostics studies performed. No further information is available.
Pt recvd vax on 24SEP92 & on 28SPE92 pt devel flu-like synd w/a fever to 101, chills, aches, & congestion in head & chest; pt was placed on Erythromycin by a MD; No further details were provided;
Narrative: COVID infection following COVID vaccine series 01/20, Pfizer, dose# 1 02/06, Pfizer, dose #2 09/09 pt cc: chills, cough, fever, dyspnea, myalgias, exposure: unknown 09/11 COVID swab, result: detected
sleeping for 48 hours; Felt more tired than usual; had generalized increased pain; swollen lymph nodes; This is a spontaneous report received from contactable reporter(s) (Other HCP) for a Pfizer sponsored program.  A 42 year-old female patient received bnt162b2 (BNT162B2), administration date 13May2021 (Batch/Lot number: unknown) at the age of 42 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "rheumatoid arthritis" (unspecified if ongoing). Concomitant medication(s) included: ASPIRIN [ACETYLSALICYLIC ACID]; VITAMIN D [VITAMIN D NOS]; XELJANZ XR taken for rheumatoid arthritis, start date: 09Mar2020. Vaccination history included: Bnt162b2 (First Dose), for COVID-19 Immunisation. The following information was reported: HYPERSOMNIA (non-serious), outcome "unknown", described as "sleeping for 48 hours"; FATIGUE (non-serious), outcome "recovering", described as "Felt more tired than usual"; PAIN (non-serious), outcome "recovering", described as "had generalized increased pain"; LYMPHADENOPATHY (non-serious), outcome "not recovered", described as "swollen lymph nodes". Therapeutic measures were taken as a result of fatigue, pain, lymphadenopathy.  Additional information: Patient missed two doses after receiving the second covid vaccine (13May2021) due to continuously sleeping for 48 hours. started prednisone (dose unspecified) on 15May2021 and md advised to take for 15 days. Feel better since starting prednisone but lymph nodes still feel swollen.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse concerning a 17 year old female with no routine medications, no medical history and no known allergies who on 12-MAR-1996 was vaccinated with the first dose of VARIVAX (Merck) (Lot# 608586/0413B, therapy dose, route and site unknown) and on 18-OCT-2007 received the second dose of VARIVAX (Merck) (Lot# 658572/1257U, therapy dose, route and site unknown). On 10-JUL-2010 the patient was seen in the office with chicken box with dried lesions and a sore throat which had started on 06-JUL-2010. The patient was treated with acetaminophen. At the time of this report, the patient was doing better. This is one of several reports received from the same source. Additional information has been requested.
Information has been received from a registered concerning an adolescent female with a history of not being sexually active who on an unspecified date was vaccinated with GARDASIL (lot# unknown) 0.5 mL injection. On an unspecified date three days later the patient developed vaginal sores. The vaginal sores went away but came back again at a later time (two episodes of this condition). Medical attention was sought. On an unspecified date two herpes virus cultures were performed and the results were negative. At the time of reporting the patient was recovering. Additional information has been requested.
Severe low back pain radiating down thighs and groin area. Tingling sensation in fingers. Unable to sleep.
Patient experienced nausea, vomiting and abdominal tenderness in the early morning hours.  She went to the ER and a CT abdominal scan diagnosed a high grade, closed loop small bowel obstruction in the upper right quadrant, and a small nonobstructing left renal calculi.  A NG tube was placed on 1/7, and a laparoscopy was performed on 1/8/23 and approximately 20 inches of ischemic small bowel was excised.  Patient was hospitalized from 1/7/23-1/12/23 and then discharged to home.
ACUTE NON ST ELEVATION MI 2/20/2021 UNSPECIFIED ANXIETY DISORDER  ACUTE RESPIRATORY FAILURE 3/6/2021 UNSPECIFIED ANXIETY DISORDER  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 3/6/2021 UNSPECIFIED ANXIETY DISORDER  CHRONIC RESPIRATORY FAILURE 4/3/2021 UNSPECIFIED ANXIETY DISORDER  ACUTE ON CHRONIC RESPIRATORY FAILURE 4/3/2021 UNSPECIFIED ANXIETY DISORDER  ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/5/2021 UNSPECIFIED ANXIETY DISORDER  ACUTE NON ST ELEVATION MI 2/20/2021 ACUTE NON ST ELEVATION MI  ACUTE RESPIRATORY FAILURE 3/6/2021 ACUTE NON ST ELEVATION MI  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 3/6/2021 ACUTE NON ST ELEVATION MI  CHRONIC RESPIRATORY FAILURE 4/3/2021 ACUTE NON ST ELEVATION MI  ACUTE ON CHRONIC RESPIRATORY FAILURE 4/3/2021 ACUTE NON ST ELEVATION MI  ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/5/2021 ACUTE NON ST ELEVATION MI  ACUTE NON ST ELEVATION MI 2/20/2021 FEEDING TUBE CARE  ACUTE RESPIRATORY FAILURE 3/6/2021 FEEDING TUBE CARE  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 3/6/2021 FEEDING TUBE CARE  CHRONIC RESPIRATORY FAILURE 4/3/2021 FEEDING TUBE CARE  ACUTE ON CHRONIC RESPIRATORY FAILURE 4/3/2021 FEEDING TUBE CARE  ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/5/2021 FEEDING TUBE CARE  ACUTE NON ST ELEVATION MI 2/20/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE RESPIRATORY FAILURE 3/6/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 3/6/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  CHRONIC RESPIRATORY FAILURE 4/3/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE ON CHRONIC RESPIRATORY FAILURE 4/3/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/5/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE NON ST ELEVATION MI 2/20/2021 EDEMA  ACUTE RESPIRATORY FAILURE 3/6/2021 EDEMA  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 3/6/2021 EDEMA  CHRONIC RESPIRATORY FAILURE 4/3/2021 EDEMA  ACUTE ON CHRONIC RESPIRATORY FAILURE 4/3/2021 EDEMA  ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/5/2021 EDEMA  ACUTE NON ST ELEVATION MI 2/20/2021 ATRIAL FIBRILLATION, PAROXYSMAL  ACUTE RESPIRATORY FAILURE 3/6/2021 ATRIAL FIBRILLATION, PAROXYSMAL  ACUTE HYPERCAPNIC RESPIRATORY FAILURE 3/6/2021 ATRIAL FIBRILLATION, PAROXYSMAL  CHRONIC RESPIRATORY FAILURE 4/3/2021 ATRIAL FIBRILLATION, PAROXYSMAL  ACUTE ON CHRONIC RESPIRATORY FAILURE 4/3/2021 ATRIAL FIBRILLATION, PAROXYSMAL  ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 3/5/2021 ATRIAL FIBRILLATION, PAROXYSMAL
My legs and arms from my elbow down including my hands were achy. It lasted from November 15th, 2022 until December 24th, 2022. It stopped when I contracted COVID-19.
Pt to MD w/classical rubellla sx consisting of enlarged posterior auricular, posterior cervical, few occipital, lymph nodes- no liver involvement & rubella-like rash on back to shoulder; joint pain & loss of appetite; won't put arms up;t103
cataract surgery on right eye; shingles out break in; chronic cough and throat issue; Throat issue; swallowing issues; gall bladder disorder; shingles outbreak / at the instrument insertion site /  in her eye following that surgery; chronic abdominal pain; shingles outbreak  in October of 2019 / shingles out break in her eye; This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (diagnosed in 2003 and had shingles outbreaks since then every 2-3 months). Concurrent medical conditions included drug allergy (patient was allergic to many different medications).   In April 2019, the patient received the 1st dose of Shingrix. In September 2019, the patient received the 2nd dose of Shingrix. In October 2019, between 5 and 7 months after receiving Shingrix and less than 2 months after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and chronic abdominal pain. On an unknown date, the patient experienced cataract (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant), chronic cough, throat discomfort, swallowing difficult and gallbladder disorder. On an unknown date, the outcome of the vaccination failure, cataract, ophthalmic herpes zoster, shingles, chronic abdominal pain, chronic cough, throat discomfort, swallowing difficult and gallbladder disorder were unknown.   It was unknown if the reporter considered the vaccination failure, cataract, ophthalmic herpes zoster, shingles, chronic abdominal pain, chronic cough, throat discomfort, swallowing difficult and gallbladder disorder to be related to Shingrix and Shingrix.  Additional details were provided as follows: The patient had a medical history of shingles, diagnosed in 2003, and had shingles outbreaks since then every 2-3 months.  The patient received dose 1 of Shingrix in April of 2019.  With the dose 1 of Shingrix she developed a large rash at the injection site two days after receiving the vaccine, and this rash lasted for 4 days and resolved.  The patient received dose 2 of Shingrix in September 2019 and in October 2019 she had gall bladder removal surgery and had chronic abdominal pain of unknown origin since October of 2019. She stated that she had a shingles outbreak in October of 2019 at the instrument insertion site for her gall bladder surgery.  The patient underwent cataract surgery on her right eye 24th June 2020 and had a shingles out break in her eye following that surgery. The patient stated she had a chronic cough and throat issue following a surgical procedure, unknown date of this procedure.  The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020193845:same patient, same reporter, different dose
PT SHOULD HAVE RECIEVED THE PEDIATRIC DOSE, BUT WAS GIVEN THE ADULT. NO ADVERSE EVENTS WERE REPORTED
Stopped communication (had been talking since 7 months) started hand flapping became disconnected with people regressed with potty training developed sandy or grainy bowel movements stopped all eye contact stopped all playing using imagination developed very picky appetite got very routine oriented started physical therapy and development therapy occupation therapy and speech therapy.
I have had ongoing fatigue, headaches, waves of nausea, dry mouth. It is still ongoing more than 2 weeks out.  I am unable to exercise.  I sometimes have to get back in bed later in the day because of fatigue.
Warm, erythematous, swelling deltoid, s/p PNEUMOVAX. Axillary nodes swollen & tender.
swelling is radiating to her exterior chest and the area hurts at touch; swelling is radiating to her exterior chest and the area hurts at touch; headache; body ache; swelling of the lymph nodes; lymphoedema; This is a spontaneous report from a nurse Medical information team. A female patient of an unspecified age (Age: 85; units: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had headache and body ache next day after receiving the Pfizer COVID-19 vaccine. On 31Dec2020, the patient reported lymphoedema or swelling of the lymph nodes. The swelling was radiating to her exterior chest and the area hurts at touch. The patient received the first dose of Pfizer COVID-19 vaccine on the 18Dec2020. The nurse wanted to know if the patient can receive the second dose of Pizer Covid-19 vaccine despite her symptoms. The outcome of the events was unknown.  Information on Lot/Batch number has been requested
Headache, Fever, Chills, Body Aches, Dizziness, Fatigue- started about 24 hours after injection. Injection at 2:30pm on Friday 3/19/2021, symptoms began around 2:00pm Saturday  3/20/2021 peaked around 7pm, then started to decrease. By 10:00am on Sunday 3/22/2021 symptoms were completely gone.
Initial unsolicited report received from a non-healthcare professional (medical assistant) on 07 June 2016. This case involves male patient (unknown age) who was vaccinated with dose of Tetanus vaccine (batch number was reported as unknown, expiration date, route and site of administration was not reported) on an unspecified date. Illness at time of vaccination was reported as unknown and pre-existing physician diagnosed allergies, birth defects, medical conditions was not reported. Concomitant medications were reported as unknown. On an unspecified date, following vaccination, patient experienced bad reaction. Lab data and corrective treatment were not reported. Outcome of event was reported as unknown. List of documents held by sender: none.
Hands and feet turned pale blue and were numb to touch 3 days after vaccine.  Hands and feet swelled 5 days after vaccine and alternate between normal and swollen (cannot wear rings).   Day 7 noticed nerve tingling  sensations at random sites (arms, legs, back, hips).  Random 'pop-up' welts that subside after 20-30 minutes.  Tingling and random swelling inside lips.
Narcolepsy; Headaches; Brain Fog; Extreme Tiredness; Dizziness; Slight chest discomfort/pain; Slight chest discomfort/pain; Nausea; Is affecting my ability to work as before and perform daily activities at times; This is a spontaneous report from a contactable consumer or other non hcp. A 50-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EW0186) via an unspecified route of administration, administered in Arm Right on 24May2021 at 17:00 (Age at Vaccination: 50 years) as dose 1, single and dose 2 via an unspecified route of administration, administered in Arm Left on 14Jun2021 at 17:00 (Batch/Lot Number: EW0217) as dose 2, single for covid-19 immunisation. Medical history and concomitant medications were not reported.The patient previously took codeine and experienced drug hypersensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not received any other medications within 2 weeks of vaccination. On 25May2021, the patient experienced narcolepsy, headaches, brain fog, tiredness, dizziness, slight chest discomfort/pain, nausea and was affecting my ability to work as before and perform daily activities at times. He had taken doctor or other healthcare professional office/clinic visit for events. He had not taken treatment. The outcome of the events were not recovered